WuXi Biologics (Cayman) Inc. (WXXWY)
OTCMKTS
· Delayed Price · Currency is USD
6.09
+0.09 (1.50%)
May 19, 2025, 9:42 AM EDT
WuXi Biologics Employees
WuXi Biologics had 12,575 employees as of December 31, 2024. The number of employees decreased by 165 or -1.30% compared to the previous year.
Employees
12,575
Change (1Y)
-165
Growth (1Y)
-1.30%
Revenue / Employee
$203,466
Profits / Employee
$36,564
Market Cap
12.24B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Tian'an Technology Group | 8 |
Elite Pharmaceuticals | 64 |
CytoDyn | 9 |
Glass House Brands | 374 |
Northwest Biotherapeutics | 25 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
WuXi Biologics News
- 20 days ago - Driving Impact Through Responsibility: WuXi Biologics Releases 2024 Sustainability Report - PRNewsWire
- 27 days ago - WuXi Biologics Recognized by CDP for Climate Change Leadership for Second Consecutive Year - PRNewsWire
- 4 weeks ago - WuXi Biologics Completes First Commercial PPQ Campaign at 15,000L Production Line in Hangzhou ... - GuruFocus
- 4 weeks ago - WuXi Biologics Completes First Commercial PPQ Campaign at 15,000L Production Line in Hangzhou Site - PRNewsWire
- 5 weeks ago - WuXi Biologics Wins Five Asia-Pacific Biopharma Excellence Awards - PRNewsWire
- 7 weeks ago - Wuxi Biologics ADR reports FY results - Seeking Alpha
- 7 weeks ago - WuXi Biologics Reports Solid 2024 Annual Results and Expects Accelerated Growth in 2025 - PRNewsWire
- 2 months ago - WuXi Biologics Celebrates Eighth Consecutive CDMO Leadership Award Win - GuruFocus